
Advancing Precision Oncology: Trends and Levers Driving Biomarker Testing Into Practice
Thursday, August 27, 2026 at 12:00 PM–1:00 PM EDT Pricing: Free for Members and Non-Members
Please note that this session is not accredited for continuing pharmacy education credit.
Program Description
Biomarker testing is central to delivering precision oncology, but adoption still varies by tumor type and care setting. Drawing on IQVIA's new Advancing Precision Oncology report, we will walk through current testing trends and the levers — clinical evidence, guideline inclusion, and institutional champions — that move biomarkers from evidence into everyday practice, along with the barriers still holding adoption back. We'll close with a quick pipeline update on what's next in oncology therapeutics.
Course summary
Speakers:
Simone Ndujiuba, PharmD, BCOP
Hematology/Oncology Expert
Vibhu Tewary
Director, IQVIA Institute for Human Data Science
Price
By registering for this event, you agree not to use any form of artificial intelligence (AI) technology to record, transcribe, or reproduce educational sessions, presentations, or discussions in any format.
Click here for more information on AMCP membership or email memberservices@amcp.org.
Required Hardware/software
AMCP Learn utilizes the Zoom Webinars platform for live webinars. For a smoother experience joining the webinar, please install the Zoom desktop client or mobile app prior to the start time. If you experience technical issues joining the webinar, please email webinars@amcp.org.

Facebook
X
LinkedIn
Forward